Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Gilead Sciences, Inc.’s (GILD) Harvoni Prescriptions Drop 1.8%
Bidness Etc.
Mon, 01/26/15 - 11:46 am
Tags:
Gilead Sciences, Harvoni, hepatitis C, AbbVie, Viekira Pak
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales
Investors.com
Wed, 01/21/15 - 05:42 pm
Tags:
Gilead Sciences, AbbVie, hepatitis C, drug pricing, Viekira Pak, Harvoni, Sovaldi
AbbVie Innovation Center Opens at the University of Illinois-Urbana Research Park
Yahoo
Tue, 01/20/15 - 01:49 pm
Tags:
AbbVie, innovation
AbbVie Inc (ABBV) Expected To Post Single-Digit Growth In Earnings, Revenue For 4Q
Bidness Etc.
Tue, 01/20/15 - 09:30 am
Tags:
AbbVie, earnings
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Tags:
Harvoni, Viekira Pak, Gilead Sciences, AbbVie, alirocumab, evolocumab, Amgen, Regeneron, Sanofi, Opdivo, Keytruda, Merck, Bristol-Myers Squibb, Novartis, CTL019, Zarxio, Pfizer, palbociclib, Saxenda, Trulicity, Afrezza, MannKind, Eli Lilly, Novo Nordisk, LCZ696, Toujeo, Breo Ellipta, GED-0301, Celgene, BiogenIdec
AbbVie Strikes Hepatitis C Discount Deal With AIDS Drug Programs
Bloomberg
Mon, 01/19/15 - 12:06 pm
Tags:
AbbVie, hepatitis C, AIDS, HIV, Viekira Pak
Aetna backs Gilead's hepatitis C treatment, gets discount
Reuters
Sat, 01/17/15 - 11:03 am
Tags:
Aetna, Gilead Sciences, hepatitis C, AbbVie, Sovaldi, Harvoni, Viekira Pak
Abandonment rates indicate room in the anti-TNF market
Medical Marketing and Media
Fri, 01/16/15 - 08:52 am
Tags:
anti-TNF, JNJ, Remicade, Humira, AbbVie, Biogen Idec
AbbVie’s hepatitis C drug gets European approval for sale
Marketwatch
Fri, 01/16/15 - 08:45 am
Tags:
AbbVie, hepatitis C, Europe, Viekira Pak
Receptos Shopping For A Partner With Strong Data In Hand
Seeking Alpha
Thu, 01/15/15 - 12:05 pm
Tags:
Receptos, AbbVie, Biogen Idec, JNJ, Novartis, RPC1063, ulcerative colitis, multiple sclerosis
Insight - Big Pharma faces up to new price pressure from aggressive insurers
Yahoo/Reuters
Thu, 01/15/15 - 09:02 am
Tags:
insurance, Big Pharma, drug pricing, Express Scripts, AbbVie, Gilead Sciences, AstraZeneca, Eli Lilly
Aetna CEO says no decision yet on how to cover hepatitis C drugs
Yahoo/Reuters
Wed, 01/14/15 - 09:01 am
Tags:
Aetna, hepatitis C, AbbVie, Gilead Sciences
AbbVie wins U.S. approval for Parkinson's treatment
Yahoo/Reuters
Mon, 01/12/15 - 08:54 am
Tags:
AbbVie, FDA, Parkinson's Disease, Duopa
Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot
Seeking Alpha
Fri, 01/9/15 - 07:02 pm
Tags:
Neurocrine Biosciences, AbbVie, Elagolix
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 2
TheStreet.com
Fri, 01/9/15 - 09:18 am
Tags:
biotech, JPMHC 2015, Juno Therapeutics, AbbVie, MannKind, EXACT Sciences, NewLink Genetics
Biotech’s Price Wars Are Just Beginning
Bloomberg
Fri, 01/9/15 - 08:01 am
Tags:
biotech, AbbVie, Gilead Sciences, drug pricing, hepatitis C
AbbVie raises 2015 outlook
Marketwatch
Thu, 01/8/15 - 10:18 pm
Tags:
AbbVie
AbbVie female health drug's success hinges on safety
Medical Marketing and Media
Thu, 01/8/15 - 04:27 pm
Tags:
AbbVie, endometriosis, Elagolix
Drug Data Dump: Pfizer, Biogen, AbbVie
Forbes
Thu, 01/8/15 - 02:46 pm
Tags:
Pfizer, AbbVie, Biogen Idec, anti-LINGO-1, optic neuritis, palbociclib, breast cancer, Elagolix, endometriosis
AbbVie, Neurocrine drug successful in endometriosis trial
Yahoo/Reuters
Thu, 01/8/15 - 08:52 am
Tags:
AbbVie, Neurocrine, endometriosis, Elagolix

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.